$MYGN
MYRIAD GENETICS INC

2020 Q4 Form 10-Q Financial Statement

#000162828020016036 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $154.6M $145.2M $93.20M
YoY Change -20.76% -22.06% -56.73%
Cost Of Revenue $47.20M $44.20M $36.70M
YoY Change -4.84% -11.07% -27.47%
Gross Profit $107.4M $101.0M $56.50M
YoY Change -26.19% -26.06% -65.72%
Gross Profit Margin 69.47% 69.56% 60.62%
Selling, General & Admin $132.8M $124.1M $107.4M
YoY Change -1.12% -8.41% -28.3%
% of Gross Profit 123.65% 122.87% 190.09%
Research & Development $18.20M $17.60M $17.40M
YoY Change -3.19% -17.37% -16.75%
% of Gross Profit 16.95% 17.43% 30.8%
Depreciation & Amortization $18.10M $2.400M $2.500M
YoY Change 503.33% -17.24% -86.41%
% of Gross Profit 16.85% 2.38% 4.42%
Operating Expenses $155.6M $141.7M $124.8M
YoY Change 1.63% -9.63% -26.89%
Operating Profit -$48.20M -$39.60M -$68.30M
YoY Change 447.73% 89.47% 1119.64%
Interest Expense -$2.600M $2.900M $3.100M
YoY Change -204.0% 0.0% -3.13%
% of Operating Profit
Other Income/Expense, Net $400.0K -$4.100M $9.800M
YoY Change -115.38% 192.86% -566.67%
Pretax Income -$50.40M -$43.70M -$58.50M
YoY Change 342.11% 95.96% 659.74%
Income Tax -$11.80M -$28.50M -$3.000M
% Of Pretax Income
Net Earnings -$37.90M -$15.20M -$55.40M
YoY Change 356.63% -26.21% 1219.05%
Net Earnings / Revenue -24.51% -10.47% -59.44%
Basic Earnings Per Share -$0.20 -$0.74
Diluted Earnings Per Share -$498.0K -$0.20 -$0.74
COMMON SHARES
Basic Shares Outstanding 75.21M shares 74.70M shares 74.60M shares
Diluted Shares Outstanding 74.70M shares 74.60M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.7M $160.4M $217.8M
YoY Change 6.43% 12.48% 59.09%
Cash & Equivalents $117.0M $118.3M $163.7M
Short-Term Investments $33.70M $42.10M $54.10M
Other Short-Term Assets $120.1M $120.4M $13.80M
YoY Change 62.74% 225.41% -66.91%
Inventory $27.10M $26.60M $29.10M
Prepaid Expenses
Receivables $89.50M $85.10M $68.10M
Other Receivables $2.000M $2.000M $2.900M
Total Short-Term Assets $389.4M $394.5M $331.7M
YoY Change 6.6% 19.73% -4.85%
LONG-TERM ASSETS
Property, Plant & Equipment $40.70M $36.70M $37.00M
YoY Change 11.51% -33.27% -35.43%
Goodwill $329.2M $328.3M $327.6M
YoY Change -19.33% -21.1% -21.48%
Intangibles $576.5M $590.9M $605.3M
YoY Change -11.78% -11.52% -11.6%
Long-Term Investments $21.00M $30.20M $37.00M
YoY Change -55.88% -41.36% -32.6%
Other Assets $2.300M $1.200M $0.00
YoY Change
Total Long-Term Assets $1.029B $1.050B $1.073B
YoY Change -15.14% -16.78% -11.63%
TOTAL ASSETS
Total Short-Term Assets $389.4M $394.5M $331.7M
Total Long-Term Assets $1.029B $1.050B $1.073B
Total Assets $1.419B $1.445B $1.405B
YoY Change -10.11% -9.22% -10.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.50M $19.10M $21.70M
YoY Change -2.38% -20.42% -34.83%
Accrued Expenses $79.10M $65.40M $75.90M
YoY Change 29.46% -10.41% -3.8%
Deferred Revenue $32.70M $32.30M $32.80M
YoY Change 808.33% 1438.1% 1390.91%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $145.9M $133.7M $147.0M
YoY Change 29.8% 15.86% 24.79%
LONG-TERM LIABILITIES
Long-Term Debt $224.8M $224.6M $224.4M
YoY Change -0.13% -0.18% -3.9%
Other Long-Term Liabilities $14.70M $10.70M $8.000M
YoY Change -83.3% 46.58% 2.56%
Total Long-Term Liabilities $239.5M $10.70M $232.4M
YoY Change 6.4% -95.39% -3.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $145.9M $133.7M $147.0M
Total Long-Term Liabilities $239.5M $10.70M $232.4M
Total Liabilities $537.8M $535.2M $486.4M
YoY Change 7.35% 3.58% 2.66%
SHAREHOLDERS EQUITY
Retained Earnings -$227.0M -$189.1M -$173.9M
YoY Change 6778.79% -779.3%
Common Stock $1.110B $1.102B $1.097B
YoY Change 2.26% 2.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $881.0M $909.3M $918.2M
YoY Change
Total Liabilities & Shareholders Equity $1.419B $1.445B $1.405B
YoY Change -10.11% -9.22% -10.12%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$37.90M -$15.20M -$55.40M
YoY Change 356.63% -26.21% 1219.05%
Depreciation, Depletion And Amortization $18.10M $2.400M $2.500M
YoY Change 503.33% -17.24% -86.41%
Cash From Operating Activities -$14.40M -$59.30M $30.00M
YoY Change 323.53% -475.32% -4.76%
INVESTING ACTIVITIES
Capital Expenditures -$6.400M -$1.500M -$2.400M
YoY Change 88.24% 7.14% 71.43%
Acquisitions
YoY Change
Other Investing Activities $17.30M $18.60M $12.70M
YoY Change -555.26% -426.32% 115.25%
Cash From Investing Activities $10.90M $17.10M $10.30M
YoY Change -251.39% -340.85% 128.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.800M -$3.900M 1.000M
YoY Change 63.64% -68.29% -103.6%
NET CHANGE
Cash From Operating Activities -14.40M -$59.30M 30.00M
Cash From Investing Activities 10.90M $17.10M 10.30M
Cash From Financing Activities 1.800M -$3.900M 1.000M
Net Change In Cash -1.700M -$45.40M 41.30M
YoY Change -82.11% 1275.76% 403.66%
FREE CASH FLOW
Cash From Operating Activities -$14.40M -$59.30M $30.00M
Capital Expenditures -$6.400M -$1.500M -$2.400M
Free Cash Flow -$8.000M -$57.80M $32.40M
YoY Change -436.05% -1.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000899923
CY2020Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q3 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2020Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q3 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 dei Entity File Number
EntityFileNumber
0-26642
CY2020Q3 dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS, INC.
CY2020Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
320 Wakara Way
CY2020Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2020Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0494517
CY2020Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84108
CY2020Q3 dei City Area Code
CityAreaCode
801
CY2020Q3 dei Local Phone Number
LocalPhoneNumber
584-3600
CY2020Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020Q3 dei Trading Symbol
TradingSymbol
MYGN
CY2020Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q3 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75210480 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118300000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163700000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42100000 USD
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
54100000 USD
CY2020Q3 mygn Prepaid Expense Excluding Prepaid Taxes Current
PrepaidExpenseExcludingPrepaidTaxesCurrent
12500000 USD
CY2020Q2 mygn Prepaid Expense Excluding Prepaid Taxes Current
PrepaidExpenseExcludingPrepaidTaxesCurrent
13800000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
26600000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
29100000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85100000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68100000 USD
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
107900000 USD
CY2020Q2 us-gaap Prepaid Taxes
PrepaidTaxes
0 USD
CY2020Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2000000.0 USD
CY2020Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2900000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
394500000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
331700000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36700000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37000000.0 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62700000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66000000.0 USD
CY2020Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
30200000 USD
CY2020Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
37000000.0 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
590900000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
605300000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
328300000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
327600000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1200000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2020Q3 us-gaap Assets
Assets
1444500000 USD
CY2020Q2 us-gaap Assets
Assets
1404600000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
19100000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21700000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65400000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75900000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13600000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13500000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3300000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
3100000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32300000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32800000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
133700000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
147000000.0 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
37400000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23500000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
75300000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26600000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
224600000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
224400000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53500000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56900000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10700000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8000000.0 USD
CY2020Q3 us-gaap Liabilities
Liabilities
535200000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
486400000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75200000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74700000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
800000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
700000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1101200000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1096600000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3600000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5200000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189100000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173900000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
909300000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
918200000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
0 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
0 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
909300000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
918200000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1444500000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1404600000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145200000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186300000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17600000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21300000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1100000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
700000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124100000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135500000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
184800000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
207200000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39600000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20900000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
400000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
900000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2900000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
2900000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1600000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
600000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4100000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1400000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43700000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22300000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28500000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-15200000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-20600000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20600000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
74700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73700000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20600000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1800000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2200000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13600000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-22800000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13600000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22800000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1088900000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-500000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8800000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2100000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1074500000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
918200000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3700000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8400000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1600000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
909300000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20600000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17700000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18200000 USD
CY2020Q3 mygn Non Cash Interest Expense
NonCashInterestExpense
200000 USD
CY2019Q3 mygn Non Cash Interest Expense
NonCashInterestExpense
100000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3300000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3200000 USD
CY2020Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-100000 USD
CY2019Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
100000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8400000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8800000 USD
CY2020Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-48400000 USD
CY2019Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5100000 USD
CY2020Q3 mygn Increase Decrease In Unrecognized Tax Benefits
IncreaseDecreaseInUnrecognizedTaxBenefits
13900000 USD
CY2019Q3 mygn Increase Decrease In Unrecognized Tax Benefits
IncreaseDecreaseInUnrecognizedTaxBenefits
400000 USD
CY2020Q3 mygn Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-1100000 USD
CY2019Q3 mygn Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
700000 USD
CY2020Q3 mygn Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
-1200000 USD
CY2019Q3 mygn Increase Decrease In Prepaid Expense Excluding Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidExpenseExcludingIncreaseDecreaseInPrepaidTaxes
-2600000 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000000.0 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16700000 USD
CY2020Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-900000 USD
CY2019Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
100000 USD
CY2020Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2600000 USD
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3100000 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
107900000 USD
CY2019Q3 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-2100000 USD
CY2020Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1200000 USD
CY2019Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3200000 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9300000 USD
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9800000 USD
CY2019Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4900000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-600000 USD
CY2019Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59300000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15800000 USD
CY2020Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1500000 USD
CY2019Q3 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1400000 USD
CY2020Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 USD
CY2019Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23100000 USD
CY2020Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18600000 USD
CY2019Q3 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17400000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17100000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7100000 USD
CY2020Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3800000 USD
CY2019Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000 USD
CY2020Q3 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
100000 USD
CY2019Q3 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3300000 USD
CY2020Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2019Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8600000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3900000 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12300000 USD
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
700000 USD
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45400000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3300000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163700000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93200000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118300000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89900000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145200000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186300000 USD
CY2020 mygn Cares Act Of2020 Medicare Payment Amount
CARESActOf2020MedicarePaymentAmount
29700000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32800000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2200000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2300000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 USD
CY2020Q3 mygn Contract With Customer Liability Prepayments
ContractWithCustomerLiabilityPrepayments
1800000 USD
CY2019Q3 mygn Contract With Customer Liability Prepayments
ContractWithCustomerLiabilityPrepayments
300000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32300000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2100000 USD
CY2020Q3 us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
In accordance with ASU 2014-09, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its contracts that are one year or less, as the revenue is expected to be recognized within the next year. Furthermore, the Company has elected not to disclose the aggregate amount of the transaction price allocated to remaining performance obligations for its agreements wherein the Company’s right to payment is in an amount that directly corresponds with the value of Company’s performance to date. However, the Company periodically enters into arrangements with customers to provide diagnostic testing and/or pharmaceutical and clinical services that may have terms longer than one year and include multiple performance obligations.
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2800000 USD
CY2020Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
2200000 USD
CY2020Q3 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q3 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118300000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
118300000 USD
CY2020Q3 mygn Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
189600000 USD
CY2020Q3 mygn Investments And Cash Accumulated Gross Unrealized Gain Before Tax
InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
1000000.0 USD
CY2020Q3 mygn Investments And Cash Accumulated Gross Unrealized Loss Before Tax
InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Investments And Cash
InvestmentsAndCash
190600000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163700000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
163700000 USD
CY2020Q2 mygn Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
253500000 USD
CY2020Q2 mygn Investments And Cash Accumulated Gross Unrealized Gain Before Tax
InvestmentsAndCashAccumulatedGrossUnrealizedGainBeforeTax
1300000 USD
CY2020Q2 mygn Investments And Cash Accumulated Gross Unrealized Loss Before Tax
InvestmentsAndCashAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q2 us-gaap Investments And Cash
InvestmentsAndCash
254800000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
41800000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
42100000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
29500000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
30200000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
0 USD
CY2020Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
116400000 USD
CY2020Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
115200000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6800000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
100000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1100000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
-300000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5900000 USD
CY2020Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
32600000 USD
CY2020Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
31800000 USD
CY2020Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114100000 USD
CY2020Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
112100000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
146700000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
143900000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110000000.0 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
106900000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36700000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37000000.0 USD
CY2020Q3 us-gaap Depreciation
Depreciation
2400000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
2900000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
327600000 USD
CY2020Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
700000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
328300000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
824300000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
238200000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
586100000 USD
CY2020Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000 USD
CY2020Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000 USD
CY2020Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
829100000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
238200000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
590900000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
823200000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
222700000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
600500000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
4800000 USD
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
828000000.0 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
222700000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
605300000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15300000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15300000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47200000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47400000 USD
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
3500000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
6100000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14700000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22400000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65400000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75900000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
226700000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
226700000 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
2100000 USD
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
2300000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
224600000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
224400000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2600000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3700000 USD
CY2020Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
8100000 USD
CY2020Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
4300000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10700000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8000000.0 USD
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000.0 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75200000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75200000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74700000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74700000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73500000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73500000 shares
CY2020Q3 mygn Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
500000 shares
CY2020 mygn Stock Issued During Period Shares Share Based Payment Arrangement And Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesShareBasedPaymentArrangementAndEmployeeStockPurchasePlans
1200000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75200000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75200000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74700000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74700000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73700000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74700000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73700000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7300000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
110700000 USD
CY2020Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2019Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4800000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.47
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
700000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.38
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
100000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
16.40
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5400000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.19
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4700000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.62
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5200000 USD
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8400000 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
8800000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28500000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.652
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.076
CY2020Q3 mygn Income Tax Expense Benefit Cares Act
IncomeTaxExpenseBenefitCARESAct
-20000000.0 USD
CY2020Q3 mygn Unrecognized Tax Benefits Increase Resulting From Cares Act
UnrecognizedTaxBenefitsIncreaseResultingFromCARESAct
14300000 USD
CY2020Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145200000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17700000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39600000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186300000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18200000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20900000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39600000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20900000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
400000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
900000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2900000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
2900000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1600000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
600000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43700000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22300000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28500000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-15200000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-20600000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-15200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-20600000 USD
CY2020Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
1300000 USD
CY2019Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
200000 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
2600000 USD
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
2800000 USD

Files In Submission

Name View Source Status
0001628280-20-016036-index-headers.html Edgar Link pending
0001628280-20-016036-index.html Edgar Link pending
0001628280-20-016036.txt Edgar Link pending
0001628280-20-016036-xbrl.zip Edgar Link pending
exhibit101-diazemploym.htm Edgar Link pending
exhibit102-diazpsuagre.htm Edgar Link pending
exhibit103-diazrsuagre.htm Edgar Link pending
exhibit104-diazperform.htm Edgar Link pending
exhibit105-diaztimexba.htm Edgar Link pending
exhibit106-diazformofs.htm Edgar Link pending
exhibit311-certificati.htm Edgar Link pending
exhibit312-certificati.htm Edgar Link pending
exhibit321-certificati.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mygn-20200930.htm Edgar Link pending
mygn-20200930.xsd Edgar Link pending
mygn-20200930_cal.xml Edgar Link unprocessable
mygn-20200930_def.xml Edgar Link unprocessable
mygn-20200930_htm.xml Edgar Link completed
mygn-20200930_lab.xml Edgar Link unprocessable
mygn-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending